Reference

The serological landscape of cytokines in cutaneous melanoma is characterized by a distinct pattern of cytokine expression that can serve as potential biomarkers. According to research published in various sources, including PubMed and Cancer Biomarkers, there is a significant increase in certain cytokines such as CCL3 (C-C motif ligand 3), CCL4 (C-C motif ligand 4), IFN-γ (Interferon gamma), and IL-10 (Interleukin 10) in melanoma patients compared to healthy controls [1][2][3]. These cytokines may play a role in the progression and immune response to melanoma. The research indicates that the levels of these cytokines can vary according to the stage of melanoma, highlighting their potential as indicators of disease progression [4][5]. The serological analysis of these cytokines could aid in the diagnosis, prognosis, and treatment monitoring of cutaneous melanoma. Images related to cytokines and melanoma can be found in various research articles, depicting the complex interactions and roles these cytokines play in the disease's pathogenesis [6][7][8][9][10]. For a more detailed understanding, it is recommended to review the full-text articles from the provided sources.